Cited by 194Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesChild and Adolescent Psychosocial and Emotional DevelopmentMemory and Neural Mechanisms

Challenges in Developing Novel Treatments for Childhood Disorders: Lessons from Research on Anxiety

Open access
Pine, Daniel S, Helfinstein, Sarah M, Bar-Haim, Yair, Nelson, Eric, Fox, Nathan A·2009·Neuropsychopharmacology

Abstract

Alterations in brain development may contribute to chronic mental disorders. Novel treatments targeted toward the early-childhood manifestations of such chronic disorders may provide unique therapeutic opportunities. However, attempts to develop and deliver novel treatments face many challenges. Work on pediatric anxiety disorders illustrates both the inherent challenges as well as the unusual opportunities for therapeutic advances. The present review summarizes three aspects of translational research on pediatric anxiety disorders as the work informs efforts to develop novel interventions. First, the review summarizes data on developmental conceptualizations of anxiety from both basic neuroscience and clinical perspectives. This summary is integrated with a discussion of the two best-established treatments, cognitive behavioral therapy and selective serotonin reuptake inhibitors. Second, the review summarizes work on attention bias to threat, considering implications for both novel treatments and translational research on neural circuitry functional development. This illustrates the manner in which clinical findings inform basic systems neuroscience research. Finally, the review summarizes work in basic science on fear learning, as studied in fear conditioning, consolidation, and extinction paradigms. This summary ends by describing potential novel treatments, illustrating the manner in which basic neuroscience informs therapeutics.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/npp.2008.113

Cites

85 of 85 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Later studies extended antidepressant treatment to pediatric anxiety disorders.

    “Later studies extended antidepressant treatment to pediatric anxiety disorders (21,22).”

    From Pediatric psychopharmacology: Too much or too little? (2013) · cites this paper as [22]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Pine, D. S., Helfinstein, S. M., Bar-Haim, Y., Nelson, E., & Fox, N. A.
Affiliations
  • National Institutes of Health (US)
  • University of Maryland, College Park (US)
  • National Institute of Mental Health (US)
Corresponding author
Pine, Daniel S
Venue
Neuropsychopharmacology
Published
2008-08-27
Volume
34
Issue
1
Pages
213-228
ISSN
  • 0893-133X (ISSN-L)
  • 1740-634X
OpenAlex
W2088212731
Cited by
194
References
83
Citations by year
2026: 1 · 2025: 8 · 2024: 6 · 2023: 9 · 2022: 4 · 2021: 6 · 2020: 4 · 2019: 7 · 2018: 13 · 2017: 7 · 2016: 14 · 2015: 20 · 2014: 12 · 2013: 13 · 2012: 14
FWCI
2.03
Type
journal article
Language
en
Open access
Locations
  • Neuropsychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Science Foundation
  • National Institutes of Health (ZIA‐MH002781)
  • National Institute of Mental Health (ZIAMH002780, ZIAMH002782)
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
Keywords
childhood anxiety disorders, child psychopathology, early intervention, cognitive behavioral therapy, selective serotonin reuptake inhibitors, attention bias to threat, fear conditioning, fear extinction, fear consolidation, translational research, brain development
MeSH terms
Animals, Anxiety, Anxiety Disorders, Attention, Child, Child Behavior, Child Behavior Disorders, Child Development, Conditioning, Psychological, Humans, Neural Pathways, Pediatrics, Anti-Anxiety Agents, Cognitive Behavioral Therapy, Biomedical Research

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review